About
Veeda Clinical Research
₹460
(+0.00 )
(0%)
5D
No infoIntroduction to Veeda Clinical Research Limited
Company Overview
Veeda Clinical Research Limited is a leading Contract Research Organization (CRO), offering end-to-end drug development services for pharmaceutical, biotechnology, and research institutions worldwide. With expertise in clinical trials, pre-clinical testing, bioequivalence studies, and biopharma services, Veeda plays a crucial role in advancing global healthcare by supporting ...
Fundamental
Veeda Clinical Research Unlisted Shares Price
₹ 460 Per Equity Share
Lot Size
100 Shares
Depository
BOTH
PAN Number
AACCC3633Q
ISIN Number
INE01HQ01026
CIN
U73100GJ2004PLC044023
RTA
Link Intime India Pvt Ltd.
Market Cap (in cr.)
₹ 2897.99
P/E Ratio
0
Book Value
168.67
Face Value
2
Total Shares
62999846
Finance
| Profit & Loss | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 196 | 288 | 409 | 388 |
| PAT | 63 | 50 | 42 | -0.3 |
| EPS | 17.6 | 9.46 | 8 | -0.04 |
| Financial Ratio | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | 34.18 | 21.53 | 25.18 | 13.66 |
| Net Profit Margin | 32.14 | 17.36 | 10.27 | -0.08 |
| Earning Per Share (Diluted) | 17.6 | 9.46 | 8 | -0.04 |
| Balance Sheet - Assets | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Fixed Assets | 38 | 185 | 236 | 190 |
| CWIP | 1 | 20 | 22 | 33 |
| Investments | 66 | 88 | 55 | 80 |
| Trade Receivables | 45 | 98 | 105 | 120 |
| Inventory | 6 | 8 | 7 | 7.2 |
| Other Assets | 129 | 278 | 310 | 1610 |
| Total Assets | 285 | 677 | 735 | 2040.2 |
| Balance Sheet - Liabilities | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Share Capital | 35.8 | 10.57 | 10.5 | 13.599 |
| Reserves | 134 | 426 | 452 | 1047 |
| Borrowings | 24 | 47 | 48 | 260 |
| Trade Payables | 12 | 25 | 22 | 247 |
| Other Liabilities | 79.2 | 168.43 | 202.5 | 473 |
| Total Liabilities | 285 | 677 | 735 | 2040.6 |